UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lowered by Albion Financial Group UT

Albion Financial Group UT decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.3% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 35,688 shares of the healthcare conglomerate’s stock after selling 834 shares during the quarter. UnitedHealth Group accounts for 1.4% of Albion Financial Group UT’s holdings, making the stock its 22nd largest position. Albion Financial Group UT’s holdings in UnitedHealth Group were worth $17,655,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of UNH. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. CGC Financial Services LLC increased its holdings in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $31,000. LFA Lugano Financial Advisors SA raised its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $40,000. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on UNH. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Truist Financial reissued a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Barclays raised their target price on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Finally, Robert W. Baird started coverage on UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective for the company. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $579.74.

Read Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $489.90 on Thursday. The business’s fifty day moving average price is $498.64 and its two-hundred day moving average price is $501.12. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The stock has a market capitalization of $450.90 billion, a price-to-earnings ratio of 29.94, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.26 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.71%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s payout ratio is currently 51.34%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.